BioSpace News Archive

Policy

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for “Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection”

Sihuan Pharmaceutical Holdings Group Ltd., the largest cardio-cerebral vascular drug manufacturer in China’s prescription drug market, announced the “non-PVC solid-liquid double chamber bag for ceftazidime/sodium chloride injection” jointly developed by the Group and its associated company Beijing Ruiye Drugs Manufacture Co.

May 27, 2019
·
6 min read
Global Surgical Clips Market 2019-2023 | Increasing Number of Surgical Procedures to Boost the Market | Technavio

A new market research study by Technavio on the global surgical clips market projects the market to grow at a CAGR of more than 5% during the period 2019-2023.

May 27, 2019
·
4 min read
Business

Molekule Consulting Announces Dr. Mark Powzaniuk, PhD, MBA as Head of Oncology Practice

Dr. Mark Powzaniuk will join Molekule Consulting as Head of Oncology Practice on May 27, 2019.

May 27, 2019
·
2 min read
The Medicines Company Presents Clinical Data Analyses for Inclisiran at 87th European Atherosclerosis Society Congress

The Medicines Company announced presentation of analyses of two clinical studies of inclisiran at the 87th European Atherosclerosis Society Congress in Maastricht, Netherlands.

May 27, 2019
·
9 min read
Drug Development

Last Patient Enrolled in the Phase 2 Trial with Transgene’s TG4010 + Nivolumab + Chemotherapy for the First-Line Treatment of Advanced Lung Cancer (NSCLC)

Transgene announces that the last patient has been included in the Phase 2 trial evaluating TG4010 in combination with Opdivo® and chemotherapy as a first-line treatment for advanced non-squamous non-small cell lung cancer with low or no expression of PD-L1 by the tumor cells.

May 27, 2019
·
6 min read
BC PharmaCare Expands Use of Biosimilar Medicines

First Province to Implement Large-Scale Biologic Switching Program

May 27, 2019
·
3 min read
Biotech Bay

BioMarin to Host Conference Call Tuesday, May 28, 2019 to Provide a Valoctocogene Roxaparvovec Phase 2 and Phase 3 Update

BioMarin Pharmaceutical Inc., announced that management will host a conference call and webcast on Tuesday, May 28 at 8:00am ET to discuss program updates.

May 27, 2019
·
1 min read
Business

CathVision Expand Board of Directors

CathVision ApS announced the addition of two industry leaders to its Board of Directors.

May 27, 2019
·
2 min read
Business

Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss

This agreement defines an exclusive option to obtain licences for joint programs including Otoferlin & Usher Type 1 and preference rights on the research pipeline in the field of genetic disorders of the inner ear in order to set up future collaborations

May 27, 2019
·
7 min read
Nordic Nanovector to Present at Redeye Pre-ASCO Seminar, Jefferies Healthcare Conference and ABGSC Oncology Seminar

Nordic Nanovector ASA announces that members of its senior management team will participate and present at the following upcoming investor conferences during May and June:

May 27, 2019
·
3 min read